Neonatal Hyperbilirubinemia Guidelines Update
Nonmember Price:
30.00
Member Price:
20.00
30.00
Quantity is required.
Quantity must be a positive whole number.
In this course, we will explore the risk factors associated with the development of severe neonatal hyperbilirubinemia (NH) and neurotoxicity. We will delve into the updated bilirubin nomograms and their significance in effectively treating neonatal hyperbilirubinemia. Furthermore, we will discuss the various treatment options available for managing neonatal hyperbilirubinemia and the approach to escalation of care prior to considering exchange transfusion.
Yoshi Ozaki, DO
Board certified in general pediatrics and pediatric hospital medicine, Dr. Yoshihiro Ozaki joined Valley Children's Hospital as a pediatric hospitalist in 2016. He also serves as Interim Chair of Primary Care and assistant professor at California Health Sciences University College of Osteopathic Medicine to train future physicians. He provides a coverage for the pediatric urgent care at Rady Children's Hospital of San Diego. Dr. Ozaki received his medical degree from Des Moines University College of Medicine in Des Moines, Iowa. He completed his pediatric residency at the University of Toledo Medical Center, Department of Pediatrics, in Toledo, Ohio. He has presented on various topics in his field at state and national conferences. Dr. Ozaki is fluent in Japanese. In his free time, he enjoys spending time with his wife and kids, playing the cello as part of an orchestra and teaching skiing.
Learning Objectives:
-Identify the risk factors for developing severe neonatal hyperbilirubinemia (NH) and neurotoxicity.
-Utilize the updated bilirubin nomograms to treat neonatal hyperbilirubinemia.
-Describe treatment options for neonatal hyperbilirubinemia and the approach to escalation of care before exchange transfusion.